ESSEX INVESTMENT MANAGEMENT CO LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 234 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$1,023,000
-0.8%
19,135
-23.5%
0.13%
-14.2%
Q3 2020$1,031,000
-19.1%
25,000
-68.3%
0.15%
+48.0%
Q4 2018$1,274,000
+53.3%
78,752
+96.7%
0.10%
+2.0%
Q3 2018$831,000
+56.8%
40,032
+140.5%
0.10%
+15.3%
Q3 2016$530,000
-1.9%
16,6470.0%0.08%
-5.6%
Q2 2016$540,000
+16.1%
16,6470.0%0.09%
+12.5%
Q1 2016$465,000
-21.6%
16,6470.0%0.08%
-14.0%
Q4 2015$593,000
+7.6%
16,6470.0%0.09%
+3.3%
Q3 2015$551,000
-20.9%
16,6470.0%0.09%
-14.3%
Q2 2015$697,000
+28.4%
16,6470.0%0.10%
+38.2%
Q1 2015$543,000
+2.6%
16,6470.0%0.08%
-1.3%
Q4 2014$529,000
+28.4%
16,6470.0%0.08%
+22.2%
Q3 2014$412,000
+9.6%
16,6470.0%0.06%
+14.5%
Q2 2014$376,000
-7.2%
16,6470.0%0.06%
-6.8%
Q1 2014$405,000
-2.6%
16,6470.0%0.06%0.0%
Q4 2013$416,000
-9.0%
16,6470.0%0.06%
-14.5%
Q3 2013$457,000
+51.3%
16,6470.0%0.07%
+30.2%
Q2 2013$302,00016,6470.05%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders